Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The cellular thermal shift assay for evaluating drug target interactions in cells.

Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, Nordlund P, Martinez Molina D.

Nat Protoc. 2014 Sep;9(9):2100-22. doi: 10.1038/nprot.2014.138. Epub 2014 Aug 7.

PMID:
25101824
2.

Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.

Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P.

Science. 2013 Jul 5;341(6141):84-7. doi: 10.1126/science.1233606.

3.

Suppressing glucose uptake and acetic acid production increases membrane protein overexpression in Escherichia coli.

Bäcklund E, Ignatushchenko M, Larsson G.

Microb Cell Fact. 2011 May 17;10:35. doi: 10.1186/1475-2859-10-35.

4.

Antileishmanial drug development: exploitation of parasite heme dependency.

Kelly JX, Ignatushchenko MV, Bouwer HG, Peyton DH, Hinrichs DJ, Winter RW, Riscoe M.

Mol Biochem Parasitol. 2003 Jan;126(1):43-9.

PMID:
12554083
5.

The flagellum and flagellar pocket of trypanosomatids.

Landfear SM, Ignatushchenko M.

Mol Biochem Parasitol. 2001 Jun;115(1):1-17. Review.

PMID:
11377735
6.

Xanthones as antimalarial agents: stage specificity.

Ignatushchenko MV, Winter RW, Riscoe M.

Am J Trop Med Hyg. 2000 Jan;62(1):77-81.

PMID:
10761728
7.

Potentiation of an antimalarial oxidant drug.

Winter RW, Ignatushchenko M, Ogundahunsi OA, Cornell KA, Oduola AM, Hinrichs DJ, Riscoe MK.

Antimicrob Agents Chemother. 1997 Jul;41(7):1449-54.

8.

Xanthones as antimalarial agents; studies of a possible mode of action.

Ignatushchenko MV, Winter RW, Bächinger HP, Hinrichs DJ, Riscoe MK.

FEBS Lett. 1997 Jun 2;409(1):67-73.

9.

Potentiation of the antimalarial agent rufigallol.

Winter RW, Cornell KA, Johnson LL, Ignatushchenko M, Hinrichs DJ, Riscoe MK.

Antimicrob Agents Chemother. 1996 Jun;40(6):1408-11.

Supplemental Content

Loading ...
Support Center